Hyderabad: Pulsus Group, headquartered in Hyderabad, has unveiled plans for an AI-based Pharma Healthcare IT Hub in Ameenpur, Sangareddy, with an anticipated investment of Rs 300 crore. This transformative initiative, announced by Dr. Srinubabu Gedela, CEO and Managing Director, during the 73rd IPC Congress, aims to create 50,000 jobs, comprising 10,000 direct roles and 40,000 indirect opportunities in associated industries and services.
The hub will integrate advanced AI applications across pharmaceutical research, development, and healthcare delivery, positioning it as a pivotal player in the healthcare and IT sectors. Situated within Ameenpur’s designated IT/ITeS Zone, the project benefits from robust infrastructure and connectivity, bolstered by support from the Telangana government and the Software Technology Parks of India.
Hyderabad’s pharmaceutical industry, recognized globally for its contributions, particularly in bulk drug production and vaccine manufacturing, underscores the city’s role as a key player in these domains. Telangana’s strategic initiatives, including its high rankings in manufacturing and per-capita income, further highlight its conducive environment for economic growth and innovation. The AI-powered hub is poised to elevate these strengths, fostering substantial advancements in Telangana’s economy and healthcare landscape.
